Adaptive two-stage optimal designs for phase II clinical studies that allow early futility stopping
From MaRDI portal
Publication:5227806
DOI10.1080/07474946.2019.1611307zbMath1422.62334OpenAlexW2959483276WikidataQ127591748 ScholiaQ127591748MaRDI QIDQ5227806
Guogen Shan, Hua Zhang, Tao Jiang
Publication date: 7 August 2019
Published in: Sequential Analysis (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/07474946.2019.1611307
Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Sequential statistical design (62L05)
Related Items (3)
Correlation coefficients for a study with repeated measures ⋮ Stopping for efficacy in single-arm phase II clinical trials ⋮ Conservative confidence intervals for the intraclass correlation coefficient for clustered binary data
Cites Work
This page was built for publication: Adaptive two-stage optimal designs for phase II clinical studies that allow early futility stopping